Sundance Diagnostics Announces it Will Target Risk of Suicide and Risk of Violence in Development of its Genetic Tests to Curb Prescription Drug Side Effects
Published: Mar 12, 2013
BOULDER, Colo.--(BUSINESS WIRE)--Sundance Diagnostics, Inc., a Boulder, CO diagnostics development company, announced today that it will focus on risk of suicide and the potential risk of acts of violence in development of its genetic tests designed to curb prescription drug side effects. The first test to be developed is for the risk of medication-induced suicidal thinking and behavior—a known serious side effect of antidepressant drugs. Following that, Sundance plans to investigate genetic markers for risk of medication-induced acts of violence—a potential prescription drug side effect.